Sponsored by kaléo
This activity is not certified for credit.
Thursday, September 8
Opioid related deaths, from both heroin and prescription opioids, have reached epidemic levels in the United States, with more people dying in 2014 than during any previous year on record. A large proportion of opioid emergencies in patients prescribed opioids for pain, resulting in life-threatening opioid induced respiratory depression (OIRD), are unintentional. Seconds count with life-threatening OIRD, and without intervention hypoxia may result in brain injury and death in as little as 4 minutes. However, the average emergency medical services (EMS) response time is approximately 9.4 minutes. Most opioid emergencies occur in the home and are witnessed by friends or family members who may be in the best position to intervene quickly prior to EMS arrival. Injectable naloxone has been FDA-approved for more than 40 years, used primarily in the hospital setting or by EMS to reverse OIRD. Many state, national, and international government and professional organizations are calling for naloxone to be readily accessible to individuals likely to witness a life-threatening opioid emergency.
During this program, the faculty will present the epidemiology of opioid emergencies, provide guidance on how to identify and communicate with at-risk pain patients, and offer strategies to help patients develop an opioid emergency plan.
After attending this PDM program, participants should be better able to:
Eric S. Edwards, MD, PhD
Jeffrey A. Gudin, MD
Sanford M. Silverman, MD